LabCompass

Zian Pan

Engineering · Purdue University West Lafayette

Early career · publishing since 2020

Publications

27

Citations

464

Est. group size

Recurring co-author estimate

Active years

7

Publishing since 2020

Research summary
AI-generated

Zian Pan's work centers on designing nanoparticle-based materials for treating cancer and other diseases, including strategies that combine drug delivery, gene silencing, and imaging in a single nanoscale platform. Much of the research focuses on nanocomposites for cancer therapy (breast, colorectal), as well as applications in Alzheimer's disease, osteoporosis, and disk degeneration. A few recent items outside this core area touch on brain-machine interfaces, pose estimation algorithms, and physics topics, suggesting some breadth beyond the main nanomedicine focus.

Nanoparticle-based drug deliveryCancer theranostics and combination therapyGene silencing (RNA/miRNA) delivery systemsNanomaterials for neurodegenerative and bone disease treatmentBiosensors and nanomaterial characterization

Publications were minimal before 2020, then rose to a steady pace of about 4-8 papers per year between 2020 and 2024, indicating a growing and active output over the past five years, though with no recorded output in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.6/year recently
1718192020: 5 publications202021: 4 publications212022: 4 publications222023: 8 publications8232024: 5 publications24252026: 1 publication26
Recent publications
Publishes in
  • Biomaterials Science×3
  • Advanced Materials×2
  • Nano Today×2
  • Journal of Nanobiotechnology×2
  • International Journal of Pharmaceutics×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile